Quid TCT - T cellula Therapy
TCR-T cell therapy, short for T cell receptor-engineered T cells, is based on gene editing technology to specifically recognize tumor antigen T cell receptors(TCR )gene, be introduced into the patient's own T cells to make them express exogenous TCR, so as to recognize and attack tumor cells and achieve the purpose of tumor treatment.
Qualis imperiumTcr - Tcellula therapytechnology
At present, no relevant guidielines for TCR-T cell products have been released at home and abroad, and TCR-T cell products have similarities with CAR T cell products in terms of production raw materials, production technology, process control, accessories, packaging containers, stability, etc., so the relevant guidelines and considerations can be referred to in quality evaluation. Maxime dividitur in salutem puritatem efficaciam et uniformitatem etc.


Currus - T cellula serum - liberum praeparatio ornamentum

Viral transduction Enhancer a / B / C (Rou / GMP)

NK et TILL cell Expansion Reagents (K562 PASTOR cell)

Cellula cytotoxicity Calcium Kit (adhaerens target cellulis)

Cellula cytotoxicity Asay Kit (suspensus scopum cellulis)

Sanguis / TEXTUS / cellula genomic DNA extraction Ornamentum (Magnetic Bead Methodo)

Car / TCR gene copy Number Proforms Kit (Multiplex QPCR)

RCL (Vsvg) Gene Copy Number Proforms Kit (qpcr)

Mycoplasma DNA Preprocessing Ornamentum (Magnetic Bead Methodo)
